Aether Industries Limited

NSEI:AETHER Stock Report

Market Cap: ₹108.9b

Aether Industries Valuation

Is AETHER undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AETHER when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AETHER's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AETHER's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AETHER?

Key metric: As AETHER is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AETHER. This is calculated by dividing AETHER's market cap by their current earnings.
What is AETHER's PE Ratio?
PE Ratio102.1x
Earnings₹1.07b
Market Cap₹108.94b

Price to Earnings Ratio vs Peers

How does AETHER's PE Ratio compare to its peers?

The above table shows the PE ratio for AETHER vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average39.6x
BLUEJET Blue Jet Healthcare
61.6x23.8%₹103.4b
500126 Procter & Gamble Health
41.9x11.3%₹89.7b
GLS Alivus Life Sciences
31.4x23.4%₹132.9b
500674 Sanofi India
23.6x-2.6%₹125.3b
AETHER Aether Industries
102.1x30.0%₹108.9b

Price-To-Earnings vs Peers: AETHER is expensive based on its Price-To-Earnings Ratio (102.1x) compared to the peer average (39.4x).

Price to Earnings Ratio vs Industry

How does AETHER's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
INDSWFTLAB Ind-Swift Laboratories
1.7xn/aUS$72.78m
524652 Ind-Swift
2.6xn/aUS$16.35m
No more companies available in this PE range
AETHER 102.1xIndustry Avg. 32.4xNo. of Companies18PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AETHER is expensive based on its Price-To-Earnings Ratio (102.1x) compared to the Indian Pharmaceuticals industry average (32.4x).

Price to Earnings Ratio vs Fair Ratio

What is AETHER's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AETHER PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio102.1x
Fair PE Ratio42.5x

Price-To-Earnings vs Fair Ratio: AETHER is expensive based on its Price-To-Earnings Ratio (102.1x) compared to the estimated Fair Price-To-Earnings Ratio (42.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AETHER forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹885.10
₹1,056.80
+19.4%
8.6%₹1,140.00₹890.00n/a5
Jan ’26₹882.50
₹1,043.60
+18.3%
11.6%₹1,140.00₹810.00n/a5
Dec ’25₹822.65
₹1,097.00
+33.3%
2.9%₹1,135.00₹1,060.00n/a4
Nov ’25₹852.85
₹1,097.00
+28.6%
2.9%₹1,135.00₹1,060.00n/a4
Oct ’25₹949.05
₹1,047.50
+10.4%
4.6%₹1,117.00₹983.00n/a4
Sep ’25₹890.25
₹1,047.50
+17.7%
4.6%₹1,117.00₹983.00n/a4
Aug ’25₹895.95
₹1,047.00
+16.9%
4.6%₹1,115.00₹983.00n/a4
Jul ’25₹927.00
₹1,046.50
+12.9%
6.7%₹1,153.00₹968.00n/a4
Jun ’25₹804.00
₹1,046.50
+30.2%
6.7%₹1,153.00₹968.00n/a4
May ’25₹833.50
₹1,084.25
+30.1%
4.2%₹1,153.00₹1,029.00n/a4
Apr ’25₹798.45
₹1,083.25
+35.7%
3.7%₹1,124.00₹1,029.00n/a4
Mar ’25₹869.60
₹1,083.25
+24.6%
3.7%₹1,124.00₹1,029.00n/a4
Feb ’25₹866.05
₹1,068.00
+23.3%
3.7%₹1,120.00₹1,024.00n/a3
Jan ’25₹882.45
₹1,071.33
+21.4%
4.1%₹1,130.00₹1,024.00₹882.503
Dec ’24₹794.85
₹1,071.33
+34.8%
4.1%₹1,130.00₹1,024.00₹822.653
Nov ’24₹870.05
₹1,095.00
+25.9%
3.2%₹1,130.00₹1,060.00₹852.852
Oct ’24₹968.45
₹1,085.00
+12.0%
2.3%₹1,110.00₹1,060.00₹949.052
Sep ’24₹990.75
₹1,085.00
+9.5%
2.3%₹1,110.00₹1,060.00₹890.252
Aug ’24₹1,093.25
₹1,085.00
-0.8%
2.3%₹1,110.00₹1,060.00₹895.952
Jul ’24₹1,067.90
₹1,070.00
+0.2%
0.9%₹1,080.00₹1,060.00₹927.002
Feb ’24₹879.10
₹892.50
+1.5%
18.8%₹1,060.00₹725.00₹866.052
Jan ’24₹839.15
₹892.50
+6.4%
18.8%₹1,060.00₹725.00₹882.452
Analyst Price Target
Consensus Narrative from 5 Analysts
₹1.06k
Fair Value
16.2% undervalued intrinsic discount
5
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 09:03
End of Day Share Price 2025/01/17 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aether Industries Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAsian Markets Securities Private Limited
Nitin AgarwalDAM Capital Advisors
Nilesh GhugeHDFC Securities Limited